Background: To evaluate the relationship between disease activity and levels of YKL-40 in
INTRODUCTION
Behçet's disease (BD) is a chronic, inflammatory disorder of unknown origin that can involve many organ systems but is mostly characterized by ulcers involving oral cavity and genitalia as well as uveitis, which tend to occur in recurrent attacks intervening remission periods. The basic pathology in BD is vasculitis, which follows a chrnoic course in the form of recurrent attacks (1) (2) (3) . Vasculitis is the hallmark of BD lesions and it is characterized by marked perivascular neutrophilic and monocytic infiltration, and sometimes mural fibrin deposition in blood vessels (4) . Despite being still unclear, the pathogenesis of the vascular lesions of BD are possibly mediated by endothelial dysfunction. Vasculitis coupled with endothelial cell activation or injury are the leading histological findings in BD (5) (6) .
YKL-40 is member of 18 glycosyl hydrolase (mammalian chitinase) family and also known aschitinase 3-like protein 1 (CHI3L1) or cartilage glycoprotein-39 (gp-39). YKL-40 is among the major proteins secreted by human articular chondrocytes, synovial cells, endothelial cells and macrophages. It is also expressed by grown neutrophils (7) . Despite its full-scale functions are largely unknown, YKL-40 is a proinflammatory protein believed to play a role in endothelial dysfunction (ED) and atherosclerosis. Both in vivo and in vitro studies have found that it is mainly located in activated macrophages and vascular smoth muscle cells that take part in inflammation and extracellular matrix remodeling, as in atherosclerotic plaques (8) (9) (10) (11) . Some cells of the immune system also express YKL-Its proinflammatory properties and role in vascular events has made it a suspected molecule in the etiology of endothelial dysfunction and atherosclerosis. Endothelial damage seems to be primary trigger of elevated serum YKL-40 level that involves in the processes of cell migration, reorganization, and tissue remodeling (12) (13) . We hypothesized that YKL-40 could have a role in the pathogenesis of BD. However, to our best knowledge, there is no study investigating the relationship between serum levels of YKL-40 and BD.
MATERIALS AND METHOD

Study population
Thirty-five patients with active disease (20 males and 15 females) and 36 patients with inactive disease (18 males and 18 females) were included. In addition, 34 age and gendermatched healthy control subjects (20 males, 14 females) were included in the study.
Diagnoses were made according to the criteria of the International Study Group for Behçet's disease (14) . Although some studies report using the clinical activity index(15) other studies report disease activity (16) (17) . In this study, clinical activity was assessed according to the methods used in previous studies. The subjects were categorized into 3 groups as the active BD group, the inactive BD group, and the control group. The study was approved by the local ethics committee of the hospital. All subjects gave informed consent before participating in the study. Patients with additional systemic disorders (malignancy, coronary artery disease, asthma, collagen vascular disease, chronic kidney and hepatic failure, pulmonary embolism, and sepsis) were excluded, so were those under the age of 18 and the pregnant patients. An informed consent was obtained from each patient. Dicle University local ethics committee approved the study (2015/256).
Determination of disease activity
BDCAF
BDCAF was used for measuring the disease activity of BD. Duration of symptoms is the major factor on which BDCAF scoring for headache, fatigue, erythema nodosum (EN) or superficial thrombophlebitis, oral and genital ulceration, arthritis, arthralgia, pustuls, nausea or vomiting or abdominal pain and diarrhoea with altered/frank blood was based. Each domain can score a minimum of 0 point and maximum of 4 points depending on its duration (0= no symptoms, 1= symptoms for 1 week, 2= symptoms for 2 weeks, 3= symptoms for 3 weeks, 4= symptoms for 4 weeks). Behcet's oculopathy index evaluated eye activity and was assigned 0 to 3 points. BDCAF score was calculated by completing a scale from 0 to 6 that evaluates the overall disease activity within the previous 4 weeks (18). Hamuryudan et al.
have verified its Turkish version for validity and reliability (19).
Determination of Levels of ESR, CRP and biochemical parameters
Venous blood samples were drawn into sterile tubes and serum and plasma samples were 
Determination of Levels of YKL-40
The fasting blood samples were centrifuged immediately, and serum specimens for YKL-40 (myBiosource, San Diego, California, USA) were frozen immediately and preserved at -80 C until analysis. The serum levels were quantified by Uscn Life Science enzyme linked immunosorbent assays (ELISAs) as ng/ml.
Statistical analyses
The Kolmogorov-Smirnov test was used to confirm that data within the ranges of normal distribution in both groups. Descriptive statistics for continuous variables were expressed as the mean and standard deviation, and categorical variables were expressed as number and percentages. The Chi-square test was used to assess differences in categoric variables. The Student's t-test was applied evaluate statistical difference in continuous variables between the two groups. Correlations between different continuous variables were evaluated by Pearson correlation analysis. The level of statistical significance was set at a two-tailed P-value of 0.05 or less. All statistical analysis was performed using SPSS for Windows (Version 16.0).
RESULTS
There were no significant differences between the three groups with respect to mean age and gender distribution (p= 0.59, p= 0.65, respectively). The active BD group and inactive BD group had a significantly different mean serum YKL-40 level than the controls (p<0.001, p< 0.001, respectively). There was, however, no significant difference between the active and inactive BD groups (p=0.9). In addition, there was detected a significant difference between active and inactive BD in terms of all the average scores of the BDCAF and clinic's impression of BD (p<0.05). The demographic, clinical, and laboratory data of three groups, and their statistical comparisons were shown in Table I.   Table II presents between active and inactive BD groups with respect to TNF-alpha level whereas serum levels of ESR and CRP were similar in both groups (42) . In our study, on the other hand, the patients with active disease had a significantly higher levels of ESR and CRP compared to the inactive disease group. Moreover, there was a significant correlation between all clinical BDCAF scores and ESR and CRP. As for the serum YKL-40 score, the active and inactive disease groups had significantly higher levels of serum YKL-40 compared with the control group although they lacked any significant difference between each other with regard to the same parameter. This result suggests that YKL-40 level may be more linked to the presence of the disease than to its activity. We believe that further studies should be conducted to clarify this subject.
Mesquida et al. reported a significant increase in the the level of the proinflammatory cytokines (interferon-gamma, TNF-alpha, and IL-17A) and CRP in active BD with uveitis compared to inactive disease and healthy controls (43) . We found that the mean Behçet's oculopathy index score was significantly greater in the active disease group than the control group, and a significant correlation existed between the oculopathy index and serum levels of ESR, CRP, and YKL-40.
CONCLUSION
Our study demonstrated that serum YKL-40 level was significantly higher in patients with active and inactive BD compared to the healthy individuals. This difference was, however, not the case between the active and inactive disease groups. In addition, a significant correlation was found between serum YKL-40 level and ESR, CRP, and BDCAF'significantly skin scores.
Limitations
Our study had some limitations. First, we did not evaluate the role of cytokines such as IL-1, IL-6, IL-8, IL-17, TNF-alpha. Second, our sample volume was relatively small. Lastly, more efficient markers are needed to diagnose Behçet disease and determine its activity and prognosis. We do not know YKL-40's sensitivity and specifity for clinical use. This subject should be addressed by future studies. 
